Anti-Snoring Devices Market Outlook, 2028

Snoring arises when the airways become blocked and the person is unable to breathe properly. This causes the soft palate and the uvula to vibrate. The anti-snoring device is a device used to treat the snoring problem. The increasing awareness of the harmful effects of snoring, the availability of advanced and effective devices, and the growing number of obese people are the major factors driving market growth. Furthermore, as the global population ages, there is an increasing demand for anti-snoring devices. Elderly individuals are more likely to suffer from snoring and related health issues, such as sleep apnea, which is driving demand for these products. Moreover, there is an increasing focus on the quality of sleep, with many individuals recognizing the importance of getting a good night's sleep for overall health and well-being. This is driving demand for anti-snoring devices as a way to improve the quality of sleep. In addition the prevalence of snoring is increasing globally, which is driving demand for anti-snoring devices. This is due to various factors, such as obesity, unhealthy lifestyle habits, and an aging population.

According to Bonafide Research's research report, "Global Anti-Snoring Device Market Outlook, 2028," the global anti-snoring device market is expected to reach more than USD 2 Billion by 2028, with a CAGR of 7.92% from USD 1.47 Billion in 2022.The market is being driven by an increase in tobacco and alcohol consumption, as well as heightened awareness of the negative consequences of snoring caused by these factors. Technological advancements in the market will drive the global anti-snoring device market throughout the forecast period. Furthermore, low-cost and minimally invasive devices, in conjunction with related product advantages, may drive demand. Furthermore, the increased prevalence of obesity, diabetes, and other chronic diseases has an impact. Furthermore, an increase in the geriatric population base susceptible to obesity has a positive impact on the growth of demand for anti-snoring products. The growing patient preference for anti-snoring devices will drive demand for such devices, boosting the market for anti-snoring devices. Additionally, rising awareness of the negative effects of snoring, increased disposable income, and advanced product development will drive demand for anti-snoring devices in the coming years.

Based on product type, the market is segmented into mandibular advancement devices, nasal devices, position control devices, chin straps, EPAP/CPAP, and tongue stabilizing devices. Among them, In the Global market, MADs have the largest market share among the various types of anti-snoring and sleep apnea devices. This is due to their effectiveness, ease of use, and comfort for patients. MADs are typically custom-fitted to each patient's mouth by a dentist or sleep specialist. Furthermore, One advantage of MADs is that they are relatively non-invasive compared to other sleep apnea treatments, such as surgery or continuous positive airway pressure (CPAP) therapy. MADs are also portable and easy to use, making them a convenient option for people who travel frequently. EPAP/CPAP is expected to grow at a higher CAGR during the forecast period. This is due to the increasing prevalence of sleep apnea in the region, as well as the growing awareness among patients and healthcare providers about the benefits of EPAP/CPAP therapy.

The market is divided into hospital, clinic, retail pharmacy, and e-commerce segments based on the distribution channel. Among them, Hospitals have the largest market share among the various types of anti-snoring and sleep apnea devices. Hospitals are the primary channel for the distribution of sleep apnea devices in global, as they are the primary source of diagnosis and treatment for sleep-disordered breathing. Hospitals offer a range of diagnostic tests, including polysomnography, which is used to diagnose sleep apnea and other sleep disorders. After diagnosis, hospitals often prescribe and dispense anti-snoring and sleep apnea devices to patients. E-commerce is expected to grow at a higher CAGR during the forecast period. One of the main drivers of the growth in e-commerce for anti-snoring and sleep apnea devices is the increasing popularity of online shopping among consumers. Many consumers prefer the convenience and accessibility of online shopping, particularly for products that are often viewed as personal or sensitive, such as anti-snoring and sleep apnea devices.

Among all the regions, North America is expected to dominate the global anti-snoring devices market in the year 2022 and is expected to do the same during the forecast period from 2023-2028. The United States leads the North America Anti-Snoring Device market. The demand for non-invasive snoring treatments, including anti-snoring devices, is growing in the USA due to the high cost and potential side effects of surgical treatments. Moreover, among the various types of anti-snoring devices, mandibular advancement devices (MADs) are the most commonly used in the USA. MADs work by moving the lower jaw forward to open up the airway and reduce snoring. According to the most recent data from the National Center for Biotechnology Information, approximately 1 out of 15 people in the United States has moderate to severe symptoms of a sleep disorder. According to the most recent Associated Professional Sleep Societies study, obstructive sleep apnea (OSA) may affect as many as 37% of adults in North, Central, and South America. Furthermore, during the forecast period, the European anti-snoring market held the second largest share of the global market. Factors such as increased awareness among individuals about the negative effects of this condition, the presence of many players in this sector, and an untapped population suffering from this condition are just a few of the key factors influencing the market's growth rate.

Some of the recent product launches include the new anti-snoring device called the Ebb Sleep System, which uses cooling technology to reduce nasal congestion and inflammation, was effective in reducing snoring and improving sleep quality in people with mild to moderate obstructive sleep apnea. Furthermore, the FDA cleared a new anti-snoring device called the Smart Nora, which uses a unique pillow insert and a bedside monitoring device to detect snoring and adjust the pillow's position to help reduce snoring. Moreover, an anti-snoring device called the NightBalance, which uses positional therapy to encourage side sleeping, was effective in reducing snoring and improving sleep quality in people with positional obstructive sleep apnea. In addition, an anti-snoring device called the Winx Sleep System, which uses negative pressure to gently suction the soft palate and tongue forward, was effective in reducing snoring and improving sleep quality in people with snoring and mild to moderate obstructive sleep apnea.

Around the world, several groups and organizations promote the use of anti-snoring devices and provide education and support to people suffering from snoring and sleep apnea. Some of the organizations include: The ASAA is a non-profit organization that provides education and support for people with sleep apnea, including information about anti-snoring devices and other treatment options. Furthermore, the BSSAA is a UK-based charity that provides education and support for people with snoring and sleep apnea, including information about anti-snoring devices and other treatments. Moreover, the ASA is a professional organization for sleep researchers and clinicians in Australia and New Zealand. They offer education and resources for people with sleep disorders, including information on anti-snoring devices and other treatments. In addition, The Sleep Foundation is a non-profit organization that provides education and support for people with sleep disorders, including snoring and sleep apnea. They offer information about a variety of treatment options, including anti-snoring devices.

Snoring and sleep apnea are common sleep disorders that affect millions of people worldwide. As the global population continues to grow and age, the prevalence of these disorders is expected to increase, driving demand for anti-snoring devices. Furthermore, obesity is a major risk factor for snoring and sleep apnea, and with the global rise in obesity rates, the prevalence of these sleep disorders is expected to increase, driving demand for anti-snoring devices. Moreover, the emergence of smart anti-snoring devices, the market entry of sleep-based start-up companies, the emergence of the latest generation of Herbst-style oral appliances, and new launches and approvals of anti-snoring devices are some significant trends in the anti-snoring devices market.

Some of the most recent entrants into the global anti-snoring device market include Hupnos, a start-up based in the United States that has developed a smart anti-snoring mask that uses sensors and algorithms to detect snoring and adjust the air pressure to prevent it. The device also provides feedback on snoring patterns and sleep quality. Furthermore, Snore Circle is a Chinese start-up that has developed a range of anti-snoring devices, including a smart snoring sensor, a smart anti-snoring pillow, and a wearable snoring aid. These devices use sound waves, vibrations, or pressure to prevent snoring and improve sleep quality. Moreover, SleepScore Labs is a US-based start-up that has developed a non-contact sleep monitoring device called SleepScore Max. The device uses bio-motion sensors and advanced algorithms to track sleep stages, detect snoring, and provide personalized sleep advice. In addition, ZQuiet is a US-based start-up that offers a range of anti-snoring devices, including mouthpieces and nasal dilators. These devices are designed to open up the airways and prevent snoring by keeping the tongue and jaw in a forward position.

Restraints:

The global anti-snoring device market is subject to various regulatory requirements, such as safety and efficacy standards. Compliance with these regulations can be challenging and costly, which can limit the entry of new players and limit the overall market growth. Furthermore, some anti-snoring devices may cause discomfort or side effects, such as dry mouth, sore throat, or nasal congestion. This can lead to low compliance and limit the overall market growth. Moreover, here are alternative treatments for snoring and sleep apnea, such as surgery or positional therapy. Some people may choose these alternatives instead of using anti-snoring devices, which can limit the overall market growth.

Developments:

• In May 2022, Illusion Aligners launched a new innovative anti-snoring device. This Illusion Aligner oral anti-snoring device is easy to wear, effective, and comfortable. It helps the user to experience an undisturbed and peaceful sleep every night.
• In February 2021, Signifier Medical Technologies launched an innovative anti-snoring device, eXciteOSA, and the device works by producing electrical muscle stimulation through a mouthpiece around the tongue. The device has four electrodes, two located above the tongue and two below the tongue. The U.S. FDA approved the commercialization of a prescription-only anti-snoring device, ''eXciteOSA''.

Companies Mentioned in this Report:

Koninklijke Philips N.V., LivaNova PLC, Fisher & Paykel Healthcare Corporation Limited., SomnoMed Inc, Medtronic plc, Meditas Ltd., ResMed Inc., Airway Management Inc., SnoreMeds Inc., PureSleep Company Inc., GlaxoSmithKline plc, ZQuiet LLC, Rhinomed Limited, Hivox Biotek Inc., Mpowrx, Nyxoah SA, Whole You, Inc., Rotech Healthcare Inc, Prosomnus Sleep Technologies, Zyppah Inc.

Considered in this report

• Geography: Global
• Historic year: 2017
• Base year: 2022
• Estimated year: 2023
• Forecast year: 2028

Aspects covered in this report

• Global Anti-Snoring market with its value and forecast along with its segments
• Region-wise Guitar market analysis
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

Regions & Countries covered in the report:

• North America (United States, Canada, Mexico)
• Europe (Germany, United Kingdom, France, Spain, Italy, Russia)
• Asia-Pacific (China, Japan, India, Australia, South Korea)
• South America (Brazil, Colombia, Argentina)
• Middle East & Africa (Saudi Arabia, South Africa, United State Emirates)

By Product Type:

• Mandibular Advancement Device
• Nasal Device
• Position Control Device
• Chin Straps
• EPAP/CPAP
• Tongue Stabilizing

By Distribution Chanel:

• Hospitals
• Clinics
• Retail Pharmacies
• E-commerce
• Others

The approach of the report:

This report consists of a combined approach of primary and secondary research. Initially, secondary research was used to get an understanding of the market and list out the companies that are present in it. The secondary research consists of third-party sources such as press releases, annual reports of companies, government-generated reports, and databases. After gathering the data from secondary sources, primary research was conducted by making telephone interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this; the publisher has started doing primary calls to consumers by equally segmenting them in regional aspects, tier aspects, age group, and gender. Once the publisher has primary data with us, we can start verifying the details obtained from secondary sources.

Intended audience

This report can be useful to industry consultants, manufacturers, suppliers, associations and organizations related to the Anti Snoring Device industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing & presentations, it will also increase competitive knowledge about the industry.